Publicacións nas que colabora con JOSEP REDON MAS (22)

2024

  1. Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves

    JMIR public health and surveillance, Vol. 10, pp. e53580

2023

  1. High miR-126-3p levels associated with cardiovascular events in a general population

    European Journal of Internal Medicine, Vol. 113, pp. 49-56

  2. Impact of Long-COVID on Health Care Burden: A Case Control Study

    Journal of Clinical Medicine, Vol. 12, Núm. 18

2022

  1. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries

    European Heart Journal, Vol. 43, Núm. 11, pp. 1104-1120

  2. Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

    ESC Heart Failure, Vol. 9, Núm. 6, pp. 4230-4239

  3. Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Prognostic value of diagnostic scales in community-acquired sepsis mortality at an emergency service. Prognosis in community-adquired sepsis

    BMC Emergency Medicine, Vol. 21, Núm. 1

  2. Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation

    Frontiers in Cardiovascular Medicine, Vol. 8

  3. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019

    Journal of Medical Virology, Vol. 93, Núm. 1, pp. 375-382

  4. Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis

    Journal of Nephrology, Vol. 34, Núm. 4, pp. 1157-1167

2020

  1. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia

    Journal of Medical Virology

2018

  1. Urinary exosome miR-146a is a potential marker of albuminuria in essential hypertension

    Journal of Translational Medicine, Vol. 16, Núm. 1

  2. Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis

    Clinical Science, Vol. 132, Núm. 5, pp. 569-579

2016

  1. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis

    Nephrology Dialysis Transplantation, Vol. 31, Núm. 5, pp. 780-789

2015

  1. Increased urinary exosomal micrornas in patients with systemic lupus erythematosus

    PLoS ONE, Vol. 10, Núm. 9

2014

  1. Should we look for silent pulmonary embolism in patients with deep venous thrombosis?

    BMC Cardiovascular Disorders, Vol. 14, Núm. 1

2008

  1. Estudio ONTARGET. Diseño y objetivos. Sus resultados. ¿Qué cuestiones pendientes resolverán?

    Revista Espanola de Cardiologia Suplementos, Vol. 8, Núm. E

2006

  1. Factores que influyen en la diferencia de medida de presión arterial entre el método auscultatorio y el oscilométrico

    Medicina Clinica, Vol. 127, Núm. 18, pp. 688-691

2004

  1. Alteración renal en la infección por el virus de la inmunodeficiencia humana

    Medicina Clinica, Vol. 122, Núm. 16, pp. 601-604

  2. Tratamiento farmacológico combinado en el manejo de la hipertensión arterial crónica esencial

    Hipertensión y riesgo vascular, Vol. 21, Núm. 3, pp. 139-157